714 related articles for article (PubMed ID: 14656067)
1. Neuropathology of cognitively normal elderly.
Knopman DS; Parisi JE; Salviati A; Floriach-Robert M; Boeve BF; Ivnik RJ; Smith GE; Dickson DW; Johnson KA; Petersen LE; McDonald WC; Braak H; Petersen RC
J Neuropathol Exp Neurol; 2003 Nov; 62(11):1087-95. PubMed ID: 14656067
[TBL] [Abstract][Full Text] [Related]
2. Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease.
Newell KL; Hyman BT; Growdon JH; Hedley-Whyte ET
J Neuropathol Exp Neurol; 1999 Nov; 58(11):1147-55. PubMed ID: 10560657
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer neuropathologic alterations in aged cognitively normal subjects.
Davis DG; Schmitt FA; Wekstein DR; Markesbery WR
J Neuropathol Exp Neurol; 1999 Apr; 58(4):376-88. PubMed ID: 10218633
[TBL] [Abstract][Full Text] [Related]
4. "Preclinical" AD revisited: neuropathology of cognitively normal older adults.
Schmitt FA; Davis DG; Wekstein DR; Smith CD; Ashford JW; Markesbery WR
Neurology; 2000 Aug; 55(3):370-6. PubMed ID: 10932270
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype.
Berg L; McKeel DW; Miller JP; Storandt M; Rubin EH; Morris JC; Baty J; Coats M; Norton J; Goate AM; Price JL; Gearing M; Mirra SS; Saunders AM
Arch Neurol; 1998 Mar; 55(3):326-35. PubMed ID: 9520006
[TBL] [Abstract][Full Text] [Related]
6. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.
Bennett DA; Schneider JA; Bienias JL; Evans DA; Wilson RS
Neurology; 2005 Mar; 64(5):834-41. PubMed ID: 15753419
[TBL] [Abstract][Full Text] [Related]
7. Position paper on diagnostic criteria for Alzheimer disease.
Hansen LA; Terry RD
Neurobiol Aging; 1997; 18(4 Suppl):S71-3. PubMed ID: 9330989
[TBL] [Abstract][Full Text] [Related]
8. Clinico-Neuropathological Findings in the Oldest Old from the Georgia Centenarian Study.
Tanprasertsuk J; Johnson EJ; Johnson MA; Poon LW; Nelson PT; Davey A; Martin P; Barbey AK; Barger K; Wang XD; Scott TM
J Alzheimers Dis; 2019; 70(1):35-49. PubMed ID: 31177211
[TBL] [Abstract][Full Text] [Related]
9. Neuropathology of Alzheimer's disease: a critical update.
Jellinger KA; Bancher C
J Neural Transm Suppl; 1998; 54():77-95. PubMed ID: 9850917
[TBL] [Abstract][Full Text] [Related]
10. Visual association pathology in preclinical Alzheimer disease.
McKee AC; Au R; Cabral HJ; Kowall NW; Seshadri S; Kubilus CA; Drake J; Wolf PA
J Neuropathol Exp Neurol; 2006 Jun; 65(6):621-30. PubMed ID: 16783172
[TBL] [Abstract][Full Text] [Related]
11. Comparison of neuropathologic criteria for the diagnosis of Alzheimer's disease.
Geddes JW; Tekirian TL; Soultanian NS; Ashford JW; Davis DG; Markesbery WR
Neurobiol Aging; 1997; 18(4 Suppl):S99-105. PubMed ID: 9330997
[TBL] [Abstract][Full Text] [Related]
12. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.
Attems J; Jellinger KA
Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156
[TBL] [Abstract][Full Text] [Related]
13. [F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging.
Marquié M; Siao Tick Chong M; Antón-Fernández A; Verwer EE; Sáez-Calveras N; Meltzer AC; Ramanan P; Amaral AC; Gonzalez J; Normandin MD; Frosch MP; Gómez-Isla T
Acta Neuropathol; 2017 Oct; 134(4):619-628. PubMed ID: 28612291
[TBL] [Abstract][Full Text] [Related]
14. Epidemiological pathology of Tau in the ageing brain: application of staging for neuropil threads (BrainNet Europe protocol) to the MRC cognitive function and ageing brain study.
Wharton SB; Minett T; Drew D; Forster G; Matthews F; Brayne C; Ince PG;
Acta Neuropathol Commun; 2016 Feb; 4():11. PubMed ID: 26857919
[TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease-related plaques in nondemented subjects.
Elobeid A; Rantakömi S; Soininen H; Alafuzoff I
Alzheimers Dement; 2014 Sep; 10(5):522-9. PubMed ID: 24742915
[TBL] [Abstract][Full Text] [Related]
16. Neuropathological and neuropsychological changes in "normal" aging: evidence for preclinical Alzheimer disease in cognitively normal individuals.
Hulette CM; Welsh-Bohmer KA; Murray MG; Saunders AM; Mash DC; McIntyre LM
J Neuropathol Exp Neurol; 1998 Dec; 57(12):1168-74. PubMed ID: 9862640
[TBL] [Abstract][Full Text] [Related]
17. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
He SR; Liu DG; Wang S; Xia YJ
Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
[TBL] [Abstract][Full Text] [Related]
18. Diffuse Amyloid-β Plaques, Neurofibrillary Tangles, and the Impact of APOE in Elderly Persons' Brains Lacking Neuritic Amyloid Plaques.
Abner EL; Neltner JH; Jicha GA; Patel E; Anderson SL; Wilcock DM; Van Eldik LJ; Nelson PT
J Alzheimers Dis; 2018; 64(4):1307-1324. PubMed ID: 30040735
[TBL] [Abstract][Full Text] [Related]
19. APOE, vascular pathology, and the AD brain.
Yip AG; McKee AC; Green RC; Wells J; Young H; Cupples LA; Farrer LA
Neurology; 2005 Jul; 65(2):259-65. PubMed ID: 16043796
[TBL] [Abstract][Full Text] [Related]
20. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
Monsell SE; Kukull WA; Roher AE; Maarouf CL; Serrano G; Beach TG; Caselli RJ; Montine TJ; Reiman EM
JAMA Neurol; 2015 Oct; 72(10):1124-31. PubMed ID: 26302353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
